Log in

NASDAQ:CYCCCyclacel Pharmaceuticals Earnings Date, Estimates & History

$4.76
-0.01 (-0.21 %)
(As of 08/7/2020 04:00 PM ET)
Add
Compare
Today's Range
$4.70
Now: $4.76
$4.81
50-Day Range
$4.36
MA: $4.59
$5.01
52-Week Range
$3.85
Now: $4.76
$19.60
Volume88,554 shs
Average Volume325,408 shs
Market Capitalization$23.13 million
P/E RatioN/A
Dividend YieldN/A
Beta1.31

Earnings

Cyclacel Pharmaceuticals (NASDAQ:CYCC) Earnings Information

Cyclacel Pharmaceuticals last released its earnings data on May 12th, 2020. The biotechnology company reported ($1.48) earnings per share for the quarter, topping the consensus estimate of ($2.90) by $1.42. Cyclacel Pharmaceuticals has generated $0.00 earnings per share over the last year. Cyclacel Pharmaceuticals has confirmed that its next quarterly earnings report will be published on Wednesday, August 12th, 2020. Cyclacel Pharmaceuticals will be holding an earnings conference call on Wednesday, August 12th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Cyclacel Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Cyclacel Pharmaceuticals (NASDAQ:CYCC) Earnings Estimates

Current Year EPS Consensus Estimate: $-2.54 EPS
Next Year EPS Consensus Estimate: $-1.83 EPS

Cyclacel Pharmaceuticals (NASDAQ CYCC) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
8/12/2020
(Confirmed)
 ($0.47)    Register (After Market Closes)
5/12/20203/31/2020($2.90)($1.48)($1.48)Transcript
2/26/2020Q4($2.40)($2.80)($0.14)Transcript
11/13/2019Q3 2019($3.40)($2.20)($0.11)N/A
8/13/20196/30/2019($3.00)($3.20)($0.16)Transcript
5/14/2019Q1 2019($3.80)($3.00)($0.15)N/A
3/27/201912/31/2018($3.40)($3.40)($0.17)$0.15 millionTranscript
11/12/2018Q3($3.40)($3.60)($0.18)Transcript
8/9/2018Q2 2018($2.40)($3.18)($0.16)N/A
5/14/2018Q1 2018($2.60)($2.34)($0.12)Transcript
11/9/2017Q3 2017($18.20)($0.91)N/A
8/9/2017Q2 2017($10.00)($0.50)Listen
5/11/2017Q1 2017($7.60)($0.38)N/A
3/28/2017Q4 2016($14.60)($13.80)($0.69)$0.21 million$0.28 millionN/A
11/14/2016Q316($18.80)($17.20)($0.86)$0.42 million$0.21 millionN/A
8/10/2016Q216($20.20)($1.01)$0.22 millionListen
5/11/2016Q116($1.80)($0.19)$512.00 million$139.00 millionListen
3/24/2016Q4($1.60)($2.00)($0.10)$0.51 million$0.42 millionListen
11/12/2015Q315($1.80)($1.60)($0.08)$0.30 million$0.72 millionListen
8/11/2015Q215($2.00)($0.10)$0.30 millionListen
5/12/2015Q115($5.00)($3.80)($0.19)$0.51 millionListen
3/24/2015Q414($5.20)($4.20)($0.21)$0.25 millionN/A
11/11/2014Q314($5.20)($4.40)($0.22)$0.74 millionN/A
8/12/2014Q214($5.60)($4.40)($0.22)$0.36 millionTranscript
5/13/2014Q114($4.80)($5.00)($0.25)$0.40 millionTranscript
3/25/2014Q4 2013($86.40)($45.60)($2.28)$0.09 million$0.30 millionN/A
11/12/2013Q3 2013($79.20)($52.80)($1.44)$0.31 millionListen
8/14/2013Q2 2013$24.00$1.20$0.03 million$0.26 millionN/A
5/13/2013Q1 2013($283.40)($14.17)$0.21 millionTranscript
3/27/2013Q4 2012($132.00)($6.12)N/A
11/12/2012Q312($7.40)Listen
8/14/2012Q2 2012($134.40)($100.80)($5.04)N/A
5/14/2012Q1 2012($134.40)($100.80)($5.04)N/A
3/29/2012Q4 2011($134.40)($119.20)($5.96)N/A
11/14/2011Q3 2011($134.40)($114.20)($5.71)N/A
8/11/2011Q2 2011($184.80)($134.40)($6.72)N/A
5/12/2011Q1 2011($151.20)($171.40)($8.57)N/A
3/23/2011Q4 2010($168.00)($122.60)($6.13)N/A
11/11/2010Q3 2010($252.00)($181.40)($9.07)N/A
8/5/2010Q2 2010($285.60)($300.80)($15.04)N/A
5/13/2010Q1 2010($252.00)($307.40)($15.37)N/A
3/23/2010Q4 2009($285.60)($295.80)($14.79)N/A
11/3/2009Q3 2009($369.60)($218.40)($10.92)N/A
8/6/2009Q2 2009($436.80)($410.00)($12.02)N/A
5/14/2009Q1 2009($504.00)($416.60)($20.83)N/A
3/31/2009Q4 2008($554.40)($653.60)($32.68)N/A
11/6/2008Q3 2008($722.40)($497.40)$22.84N/A
8/7/2008Q2 2008($638.40)($702.40)($35.12)N/A
5/9/2008Q1 2008($655.20)($514.20)($25.71)N/A
3/11/2008Q4 2007($688.80)($934.20)($46.71)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 8/10/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.